STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver

被引:101
作者
Davey, HW
McLachlan, MJ
Wilkins, RJ
Hilton, DJ
Adams, TE
机构
[1] Dairy Sci Grp, Hamilton, New Zealand
[2] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand
[3] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
[4] Cooperat Res Ctr Cellular Growth Factors, Parkville, Vic 3050, Australia
[5] CSIRO, Div Mol Sci, Parkville, Vic 3052, Australia
关键词
SOCS; STAT5b; growth hormone; gene expression;
D O I
10.1016/S0303-7207(99)00175-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Suppressor of cytokine signalling (SOCS) proteins act as part of a classical negative feedback loop regulating cytokine signal transduction. Expression of SOCS proteins is induced in response to cytokines and down-regulates the cytokine signal by inhibiting the JAK/STAT pathway. Growth hormone (GH) was previously shown to induce strong transient expression of SOCS-3 and to a lesser extent CIS, SOCS-1 and SOCS-2 in mouse liver (Adams, T.E., Hansen, J.A., Starr, R., Nicola, N.A., Hilton, D.J., Billestrup, N., 1998. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of,cytokine receptor signalling. J. Biol. Chem. 273, 1285-1287.). In this work we have compared GH-induced SOCS gene expression in wild-type and STAT5b-deficient mice, and show that: STAT5b is required for the induction of SOCS-2 and SOCS-3 in liver. In contrast, the absence of STAT5b has no effect on the GH-induced expression of CIS and SOCS-2 mRNA in the mammary gland. Suprisingly, there is no activation of SOCS-3 expression in mammary glands of wild-type and STAT5b mutant mice following GH administration. These results highlight both tissue- and factor-specific differences in the regulation of SOCS gene expression by STAT5a/b. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 46 条
[1]
Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling [J].
Adams, TE ;
Hansen, JA ;
Starr, R ;
Nicola, NA ;
Hilton, DJ ;
Billestrup, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1285-1287
[2]
Functionally distinct isoforms of STAT5 are generated by protein processing [J].
Azam, M ;
Lee, C ;
Strehlow, I ;
Schindler, C .
IMMUNITY, 1997, 6 (06) :691-701
[3]
Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway [J].
Beadling, C ;
Ng, J ;
Babbage, JW ;
Cantrell, DA .
EMBO JOURNAL, 1996, 15 (08) :1902-1913
[4]
Specific inhibition of Stat3 signal transduction by PIAS3 [J].
Chung, CD ;
Liao, JY ;
Liu, B ;
Rao, XP ;
Jay, P ;
Berta, P ;
Shuai, K .
SCIENCE, 1997, 278 (5344) :1803-1805
[5]
GENOMIC SEQUENCING [J].
CHURCH, GM ;
GILBERT, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07) :1991-1995
[6]
DISTRIBUTION OF THE MAMMALIAN STAT GENE FAMILY IN MOUSE CHROMOSOMES [J].
COPELAND, NG ;
GILBERT, DJ ;
SCHINDLER, C ;
ZHONG, Z ;
WEN, Z ;
DARNELL, JE ;
MUI, ALF ;
MIYAJIMA, A ;
QUELLE, FW ;
IHLE, JN ;
JENKINS, NA .
GENOMICS, 1995, 29 (01) :225-228
[7]
STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[8]
De Sepulveda P, 1999, EMBO J, V18, P904
[9]
Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor [J].
Dey, BR ;
Spence, SL ;
Nissley, P ;
Furlanetto, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :24095-24101
[10]
A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924